Condition: Lung Neoplasms · Surgery · Sponsor: The First Affiliated Hospital with Nanjing Medical University
This study aims to investigate whether segmentectomy had non-inferiority long-term oncological effects (disease-free survival and overall survival) compared with lobectomy in the treatment of patients with early-stage non-small cell lung cancer ≤ 2 cm in the middle third of lung field.
This description comes directly from the study's public registry record.
Zhihua Li, M.D. · +86-025-68303743 · lizhihua_njmu@126.com
Weibing Wu, M.D. · +86-025-68303743 · wuweibing95@163.com
Always discuss trial participation with your own doctor first.
| Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04944563